Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001415889-25-021175·Orchestra BioMed Holdings, Inc.
Schedule 13D ownership disclosure
Orchestra BioMed Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 68572M106
Event date: 2025-08-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LPReported CIK 0001493215
Shares: 8,306,063.00 · Class: 15.4%
- RTW Master Fund, Ltd.Reported CIK 0001493219
Shares: 4,394,985.00 · Class: 8.1%
- RTW Innovation Master Fund, Ltd.Reported CIK 0001776733
Shares: 3,053,082.00 · Class: 5.7%
- Roderick WongReported CIK 0001493280
Shares: 8,306,063.00 · Class: 15.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021175
- Form type
- SCHEDULE 13D/A
- Filer
- Orchestra BioMed Holdings, Inc.
- CIK
- CIK 1814114
- Filed
- Aug 06, 2025
- Reporting period
- Aug 04, 2025
- Description
- Schedule 13D beneficial ownership